Ligand validation:8IR9

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IR9_HTG_B_623	81%	45%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1
8IR9_HTG_b_625	66%	35%	0.11	0.914	1.1	1.46	2	4	0	0	100%	1
8IR9_HTG_o_301	36%	35%	0.162	0.855	1.06	1.49	2	4	0	0	100%	1
8IR9_HTG_b_622	34%	24%	0.176	0.861	1.15	1.94	2	7	0	0	100%	1
8IR9_HTG_B_621	19%	41%	0.265	0.857	0.77	1.49	1	1	0	0	100%	1
8IR9_HTG_c_522	17%	34%	0.26	0.837	0.94	1.64	1	3	0	0	100%	1
8IR9_HTG_C_522	12%	40%	0.306	0.84	0.89	1.43	1	1	0	0	100%	1
8IR9_HTG_d_409	9%	34%	0.287	0.802	1.01	1.6	1	2	0	0	84%	1
8IR9_HTG_V_202	8%	65%	0.383	0.938	0.31	1.01	-	1	0	0	58%	1
8IR9_HTG_D_410	3%	33%	0.288	0.661	1.04	1.59	1	1	0	0	84%	1
8IR9_HTG_b_623	1%	27%	0.491	0.677	1.06	1.88	1	2	0	0	100%	1
5V2C_HTG_O_303	94%	33%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	40%	0.092	0.971	1.13	1.22	2	1	0	0	100%	1
5WS6_HTG_b_628	88%	46%	0.076	0.952	0.83	1.23	1	3	0	0	100%	1
5GTI_HTG_b_625	87%	37%	0.061	0.933	0.99	1.48	2	3	0	0	100%	1
8IR7_HTG_b_625	81%	37%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
3EJD_HTG_A_100	98%	9%	0.031	0.991	3.37	1.11	2	1	2	0	79%	1
3EJE_HTG_A_100	97%	9%	0.036	0.986	3.34	1.2	2	1	0	0	79%	1
2HPY_HTG_A_1508	94%	7%	0.068	0.968	2.48	2.29	8	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.